Monday, April 16, 2012

India's Piramal buys Bayer's potential Alzheimer drug


11:14 p.m. EDT, April 15, 2012

ndian drugmaker Piramal Healthcare has agreed to buy a research and development portfolio from Bayer AG, the company said, in a deal that gives Piramal rights to florbetaben, a possible Alzheimer treatment.

Posted via email from Jack's posterous

No comments: